Amgen's virus-based cancer drug wins European green light

October 23, 2015 11:15 AM

21 0

LONDON Oct 23 An experimental Amgen drug based on a tumour-killing virus was given a green light by European regulators on Friday, paving the way for the novel treatment's approval within a couple of months.

The decision is a further milestone for a technology that has long fascinated scientists but has previously proved difficult to harness.

Also read: Horizon Pharma drug fails key study in rare neuromuscular disease

Read more

To category page

Loading...